Peer-reviewed articles

Hanly P, Pearce A, Sharp L. The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Review of Pharmacoeconomics & Outcomes Research. 2014;14(3):355-377. doi:10.1586/14737167.2014.909287

Lonergan BJ, Meaney S, Perry IJ, et al. Smokers Still Underestimate the Risks Posed by Secondhand Smoke: A Repeated Cross-sectional Study. Nicotine Tob Res. 2014;16(8):1121-1128. doi:10.1093/ntr/ntu046

Sheridan J, Walsh P, Kevans D, et al. Determinants of short- and long-term survival from colorectal cancer in very elderly patients. J Geriatr Oncol. Published online May 18, 2014. doi:10.1016/j.jgo.2014.04.005

Bannon FJ, McCaughan JA, Traynor C, et al. Surveillance of Nonmelanoma Skin Cancer Incidence Rates in Kidney Transplant Recipients in Ireland. Transplantation. Published online May 3, 2014. doi:10.1097/TP.0000000000000115

Dee A, Kearns K, O’Neill C, et al. The direct and indirect costs of both overweight and obesity: a systematic review. BMC Research Notes. 2014;7(1):242. doi:10.1186/1756-0500-7-242

O’Connor M, Costello L, Murphy J, et al. “I don’t care whether it’s HPV or ABC, I just want to know if I have cancer.” Factors influencing women’s emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study. BJOG. Published online April 1, 2014. doi:10.1111/1471-0528.12741

Sharp L, Cotton S, Cruickshank M, et al. The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance. J Low Genit Tract Dis. 2014;18(2):142-150. doi:10.1097/LGT.0b013e31829c97d8

Hanly PA, Sharp L. The cost of lost productivity due to premature cancer-related mortality: an economic measure of the cancer burden. BMC Cancer. 2014;14(1):224. doi:10.1186/1471-2407-14-224

Deady S, Sharp L, Comber H. Increasing skin cancer incidence in young, affluent, urban populations: a challenge for prevention. Br J Dermatol. Published online March 26, 2014. doi:10.1111/bjd.12988

Wells M, Amir Z, Cox T, et al. Time to act: the challenges of working during and after cancer, initiatives in research and practice. Eur J Oncol Nurs. 2014;18(1):1-2. doi:10.1016/j.ejon.2014.01.001

Steliarova-Foucher E, O’Callaghan M, Ferlay J, et al. The European Cancer Observatory: A new data resource. European Journal of Cancer. Published online February 2014. doi:10.1016/j.ejca.2014.01.027

Sharp L, Donnelly D, Hegarty A, et al. Risk of Several Cancers is Higher in Urban Areas after Adjusting for Socioeconomic Status. Results from a Two-Country Population-Based Study of 18 Common Cancers. Journal of Urban Health. Published online January 29, 2014. doi:10.1007/s11524-013-9846-3

Barron TI, Flahavan EM, Sharp L, Bennett K, Visvanathan K. Recent Prediagnostic Aspirin Use, Lymph Node Involvement, and 5-Year Mortality in Women with Stage I–III Breast Cancer: A Nationwide Population-Based Cohort Study. Cancer Res. 2014;74(15):4065-4077. doi:10.1158/0008-5472.CAN-13-2679

Spillane S, Bennett K, Sharp L, Barron TI. Metformin exposure and disseminated disease in patients with colorectal cancer. Cancer Epidemiol. Published online January 4, 2014. doi:10.1016/j.canep.2013.12.003

Jennings CJ, Walsh PM, Deady S, Harvey BJ, Thomas W. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009. Cancer Epidemiol. Published online January 3, 2014. doi:10.1016/j.canep.2013.12.002

Flahavan EM, Bennett K, Sharp L, Barron TI. A cohort study investigating aspirin use and survival in men with prostate cancer. Ann Oncol. 2014;25(1):154-159. doi:10.1093/annonc/mdt428

Gatta G, Botta L, Rossi S, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. The Lancet Oncology. 2014;15(1):35-47. doi:10.1016/S1470-2045(13)70548-5

De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. 2014;15(1):23-34. doi:10.1016/S1470-2045(13)70546-1

Zanetti R, Calvia M, Bordoni A, et al. Economic evaluation of cancer registration in Europe. J Registry Manag. 2014;41(1):31-37.

McRae J, Martin C, O¿Leary J, Sharp L. “If you can’t treat HPV, why test for it?” Women’s attitudes to the changing face of cervical cancer prevention: a focus group study. BMC Women’s Health. 2014;14(1):64. doi:10.1186/1472-6874-14-64

Clarke N, McDevitt J, Kearney PM, Sharp L. Increasing late stage colorectal cancer and rectal cancer mortality demonstrates the need for screening: a population based study in Ireland, 1994-2010. BMC Gastroenterology. 2014;14(1):92. doi:10.1186/1471-230X-14-92

Sharp L, Cotton S, Little J, et al. Psychosocial Impact of Alternative Management Policies for Low-Grade Cervical Abnormalities: Results from the TOMBOLA Randomised Controlled Trial. PLoS One. 2013;8(12). doi:10.1371/journal.pone.0080092

Sharp L, Carsin AE, Cantwell MM, Anderson LA, Murray LJ. Intakes of Dietary Folate and Other B Vitamins Are Associated with Risks of Esophageal Adenocarcinoma, Barrett’s Esophagus, and Reflux Esophagitis. J Nutr. 2013;143(12):1966-1973. doi:10.3945/jn.113.174664

Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention. Best Pract Res Clin Gastroenterol. 2013;27(6):933-947. doi:10.1016/j.bpg.2013.09.005

Gurumurthy M, Cotton SC, Sharp L, et al. Postcolposcopy Management of Women With Histologically Proven CIN 1: Results From TOMBOLA. J Low Genit Tract Dis. Published online November 21, 2013. doi:10.1097/LGT.0b013e3182a1772c